Report Detail
Global Famitinib Malate Capsules Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4706248 |
- 09 June, 2026 |
- Global |
- 73 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Famitinib Malate Capsules market size was valued at US$ 10.70 million in 2025 and is forecast to a readjusted size of US$ 42.99 million by 2032 with a CAGR of 6.2% during review period.
Famitinib malate is an oral multi-target tyrosine kinase inhibitor that mainly acts on various kinase targets such as VEGFR, PDGFR, and c-Kit. It exerts anti-tumor effects by inhibiting tumor angiogenesis and blocking signal transduction for tumor cell proliferation. Formulated as oral capsules in the form of malate salt, it is mainly used clinically for the treatment of advanced or metastatic solid tumors. It is often combined with immune checkpoint inhibitors to improve therapeutic efficacy. Characterized by a broad target spectrum, convenient oral administration, and a wide anti-tumor range, it has clear clinical application value in gynecological tumors, gastrointestinal tumors and other fields.In 2025, global production of Famitinib Malate Capsules reached approximately 1.2 million bottles.
Famitinib malate, a Class 1 innovative drug independently developed by Hengrui Medicine, is the world's first multi-target tyrosine kinase inhibitor approved for the treatment of cervical cancer. Centered on the targeted-immunotherapy regimen in combination with camrelizumab, it fills a key gap in the second-line treatment of recurrent or metastatic cervical cancer. Positioned for patients who have not received bevacizumab, it has formed differentiated competitiveness in the domestic cervical cancer treatment field thanks to its convenient oral administration, broad target coverage and remarkable efficacy. Following its inclusion in the National Reimbursement Drug List at the end of 2025, treatment costs dropped significantly, patient accessibility improved substantially, and clinical penetration accelerated. In the current market landscape, as the only domestically approved targeted-immunotherapy combination regimen for cervical cancer, famitinib competes with imported anti-angiogenic agents, domestic similar TKIs and bispecific antibodies. It holds a core position in second-line treatment by virtue of its medical insurance advantages, local R&D strengths and superior survival benefit data. Meanwhile, its ongoing research covers first-line cervical cancer and other solid tumors, which is expected to further expand its market space and consolidate its leading position in the field of oncology therapy.
This report is a detailed and comprehensive analysis for global Famitinib Malate Capsules market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Famitinib Malate Capsules market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Famitinib Malate Capsules market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Famitinib Malate Capsules market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Famitinib Malate Capsules market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Famitinib Malate Capsules
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Famitinib Malate Capsules market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jiangsu Hengrui Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Famitinib Malate Capsules market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
5 mg per capsule
10 mg per capsule
Market segment by Combination Therapy
Camrelizumab
Chemotherapeutic Agents
Market segment by Production Technology
Innovator
Generic
Market segment by Sales Channels
Hospital
Retail
Online
Market segment by Application
Recurrent or Metastatic Cervical Cancer
Advanced Gastrointestinal Tumors
Other Advanced Solid Tumors
Major players covered
Jiangsu Hengrui Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Famitinib Malate Capsules product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Famitinib Malate Capsules, with price, sales quantity, revenue, and global market share of Famitinib Malate Capsules from 2021 to 2026.
Chapter 3, the Famitinib Malate Capsules competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Famitinib Malate Capsules breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Famitinib Malate Capsules market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Famitinib Malate Capsules.
Chapter 14 and 15, to describe Famitinib Malate Capsules sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Famitinib Malate Capsules Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 5 mg per capsule
- 1.3.3 10 mg per capsule
- 1.4 Market Analysis by Combination Therapy
- 1.4.1 Overview: Global Famitinib Malate Capsules Consumption Value by Combination Therapy: 2021 Versus 2025 Versus 2032
- 1.4.2 Camrelizumab
- 1.4.3 Chemotherapeutic Agents
- 1.5 Market Analysis by Production Technology
- 1.5.1 Overview: Global Famitinib Malate Capsules Consumption Value by Production Technology: 2021 Versus 2025 Versus 2032
- 1.5.2 Innovator
- 1.5.3 Generic
- 1.6 Market Analysis by Sales Channels
- 1.6.1 Overview: Global Famitinib Malate Capsules Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
- 1.6.2 Hospital
- 1.6.3 Retail
- 1.6.4 Online
- 1.7 Market Analysis by Application
- 1.7.1 Overview: Global Famitinib Malate Capsules Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.7.2 Recurrent or Metastatic Cervical Cancer
- 1.7.3 Advanced Gastrointestinal Tumors
- 1.7.4 Other Advanced Solid Tumors
- 1.8 Global Famitinib Malate Capsules Market Size & Forecast
- 1.8.1 Global Famitinib Malate Capsules Consumption Value (2021 & 2025 & 2032)
- 1.8.2 Global Famitinib Malate Capsules Sales Quantity (2021-2032)
- 1.8.3 Global Famitinib Malate Capsules Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Jiangsu Hengrui Pharmaceutical
- 2.1.1 Jiangsu Hengrui Pharmaceutical Details
- 2.1.2 Jiangsu Hengrui Pharmaceutical Major Business
- 2.1.3 Jiangsu Hengrui Pharmaceutical Famitinib Malate Capsules Product and Services
- 2.1.4 Jiangsu Hengrui Pharmaceutical Famitinib Malate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Jiangsu Hengrui Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Famitinib Malate Capsules by Manufacturer
- 3.1 Global Famitinib Malate Capsules Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Famitinib Malate Capsules Revenue by Manufacturer (2021-2026)
- 3.3 Global Famitinib Malate Capsules Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Famitinib Malate Capsules by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Famitinib Malate Capsules Manufacturer Market Share in 2025
- 3.4.3 Top 6 Famitinib Malate Capsules Manufacturer Market Share in 2025
- 3.5 Famitinib Malate Capsules Market: Overall Company Footprint Analysis
- 3.5.1 Famitinib Malate Capsules Market: Region Footprint
- 3.5.2 Famitinib Malate Capsules Market: Company Product Type Footprint
- 3.5.3 Famitinib Malate Capsules Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Famitinib Malate Capsules Market Size by Region
- 4.1.1 Global Famitinib Malate Capsules Sales Quantity by Region (2021-2032)
- 4.1.2 Global Famitinib Malate Capsules Consumption Value by Region (2021-2032)
- 4.1.3 Global Famitinib Malate Capsules Average Price by Region (2021-2032)
- 4.2 North America Famitinib Malate Capsules Consumption Value (2021-2032)
- 4.3 Europe Famitinib Malate Capsules Consumption Value (2021-2032)
- 4.4 Asia-Pacific Famitinib Malate Capsules Consumption Value (2021-2032)
- 4.5 South America Famitinib Malate Capsules Consumption Value (2021-2032)
- 4.6 Middle East & Africa Famitinib Malate Capsules Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Famitinib Malate Capsules Sales Quantity by Type (2021-2032)
- 5.2 Global Famitinib Malate Capsules Consumption Value by Type (2021-2032)
- 5.3 Global Famitinib Malate Capsules Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Famitinib Malate Capsules Sales Quantity by Application (2021-2032)
- 6.2 Global Famitinib Malate Capsules Consumption Value by Application (2021-2032)
- 6.3 Global Famitinib Malate Capsules Average Price by Application (2021-2032)
7 North America
- 7.1 North America Famitinib Malate Capsules Sales Quantity by Type (2021-2032)
- 7.2 North America Famitinib Malate Capsules Sales Quantity by Application (2021-2032)
- 7.3 North America Famitinib Malate Capsules Market Size by Country
- 7.3.1 North America Famitinib Malate Capsules Sales Quantity by Country (2021-2032)
- 7.3.2 North America Famitinib Malate Capsules Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Famitinib Malate Capsules Sales Quantity by Type (2021-2032)
- 8.2 Europe Famitinib Malate Capsules Sales Quantity by Application (2021-2032)
- 8.3 Europe Famitinib Malate Capsules Market Size by Country
- 8.3.1 Europe Famitinib Malate Capsules Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Famitinib Malate Capsules Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Famitinib Malate Capsules Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Famitinib Malate Capsules Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Famitinib Malate Capsules Market Size by Region
- 9.3.1 Asia-Pacific Famitinib Malate Capsules Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Famitinib Malate Capsules Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Famitinib Malate Capsules Sales Quantity by Type (2021-2032)
- 10.2 South America Famitinib Malate Capsules Sales Quantity by Application (2021-2032)
- 10.3 South America Famitinib Malate Capsules Market Size by Country
- 10.3.1 South America Famitinib Malate Capsules Sales Quantity by Country (2021-2032)
- 10.3.2 South America Famitinib Malate Capsules Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Famitinib Malate Capsules Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Famitinib Malate Capsules Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Famitinib Malate Capsules Market Size by Country
- 11.3.1 Middle East & Africa Famitinib Malate Capsules Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Famitinib Malate Capsules Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Famitinib Malate Capsules Market Drivers
- 12.2 Famitinib Malate Capsules Market Restraints
- 12.3 Famitinib Malate Capsules Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Famitinib Malate Capsules and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Famitinib Malate Capsules
- 13.3 Famitinib Malate Capsules Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Famitinib Malate Capsules Typical Distributors
- 14.3 Famitinib Malate Capsules Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Famitinib Malate Capsules. Industry analysis & Market Report on Famitinib Malate Capsules is a syndicated market report, published as Global Famitinib Malate Capsules Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Famitinib Malate Capsules market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
